Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Equity Bottom-Up

<ul>
<li>Futura Medical specialises in the development and commercialisation of innovative sexual health products.</li>
<li>The lead product is Eroxon, which is a clinically proven treatment for erectile dysfunction.</li>
<li>In November 2025, £2.75m was raised at 1p and the shares are down from a 52 week high of 34p. </li>
</ul>


Futura Medical specialises in the development and commercialisation of innovative sexual health products.
The lead product is Eroxon, which is a clinically proven treatment for erectile dysfunction.
In November 2025, £2.75m was raised at 1p and the shares are down from a 52 week high of 34p. 


Futura Medical

Friday Take Away: 21 November 2025